Monte Rosa Therapeutics, Inc. (GLUE) Depreciation USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Monte Rosa Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2021 to 2024.
  • Monte Rosa Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $1.9 M, a 64.8% increase year-over-year.
  • Monte Rosa Therapeutics, Inc. Depreciation for the twelve months ending March 31, 2024 was $6.97 M, a 68.2% increase year-over-year.
  • Monte Rosa Therapeutics, Inc. annual Depreciation for 2023 was $6.22 M, a 66.1% increase from 2022.
  • Monte Rosa Therapeutics, Inc. annual Depreciation for 2022 was $3.75 M, a 75.7% increase from 2021.
  • Monte Rosa Therapeutics, Inc. annual Depreciation for 2021 was $2.13 M, a 297% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6.97 M $1.9 M +$746 K +64.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $6.22 M $1.85 M +$776 K +72.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $5.45 M $1.83 M +$801 K +77.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.65 M $1.39 M +$502 K +56.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $4.14 M $1.15 M +$398 K +52.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $3.75 M $1.07 M +$212 K +24.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $3.53 M $1.03 M +$433 K +72.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.1 M $889 K +$489 K +122% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.61 M $753 K +$479 K +175% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.13 M $858 K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $600 K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $400 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $274 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.